Heart failure, kidney disease, sleep apnea, diabetes, back pain – disruptive medical devices emerging from Israel could transform treatment for these conditions
Medical devices that could disrupt the healthcare field will be among the cutting-edge technologies to be revealed at the 18th annual MIXiii-Biomed Conference and Exhibition, May 14-16 in Tel Aviv.
More than 1,000 scientists, key opinion leaders, entrepreneurs and investors from 45 countries are expected to join 5,000 Israeli counterparts at the event.
Sessions will explore topics such as gene editing and gene therapy, artificial intelligence and digital health, personalized medicine, transformative cancer therapies, new kinds of cell therapies, and medical cannabis, in addition to disruptive devices.
“Disruptive technologies are those that will bring significant value and benefit for patients by changing the current medical practice,” says Dr. Irit Yaniv, co-chair of the track with Dr. Ron Ginor, general partner at healthcare investment firm Orbimed.
“For example, if today we treat type 2 diabetes with medication and even insulin, the idea is to bring a device that changes this practice and works better than drugs. Or if today there is no effective treatment for patients with heart failure, disruptive technologies look for a better solution.”
Formerly a practicing physician and biomed entrepreneur, Yaniv is responsible for the early-stage innovation portfolio as general partner at medical device fund Accelmed. -- More....
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.
Medical devices that could disrupt the healthcare field will be among the cutting-edge technologies to be revealed at the 18th annual MIXiii-Biomed Conference and Exhibition, May 14-16 in Tel Aviv.
More than 1,000 scientists, key opinion leaders, entrepreneurs and investors from 45 countries are expected to join 5,000 Israeli counterparts at the event.
